Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Pharmacotherapy for conduct disorder in children and adolescents].

Levy T, Bloch Y.

Harefuah. 2012 Jul;151(7):421-6, 435, 434. Review. Hebrew.

PMID:
23002695
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.

Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, Faraone SV, Biederman J.

J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):749-62.e39. doi: 10.1016/j.jaac.2011.05.011. Epub 2011 Jul 13. Review.

PMID:
21784295
5.

Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study.

Masi G, Milone A, Manfredi A, Pari C, Paziente A, Millepiedi S.

CNS Drugs. 2009;23(1):59-69. doi: 10.2165/0023210-200923010-00004.

PMID:
19062775
6.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
7.

Drug treatment of conduct disorder in young people.

Gérardin P, Cohen D, Mazet P, Flament MF.

Eur Neuropsychopharmacol. 2002 Oct;12(5):361-70.

PMID:
12208553
8.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
9.

Treatment of aggression in children and adolescents with autism and conduct disorder.

McDougle CJ, Stigler KA, Posey DJ.

J Clin Psychiatry. 2003;64 Suppl 4:16-25. Review.

10.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

11.

Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.

Connor DF, Carlson GA, Chang KD, Daniolos PT, Ferziger R, Findling RL, Hutchinson JG, Malone RP, Halperin JM, Plattner B, Post RM, Reynolds DL, Rogers KM, Saxena K, Steiner H; Stanford/Howard/AACAP Workgroup on Juvenile Impulsivity and Aggression.

J Clin Psychiatry. 2006 May;67(5):808-20. Review.

PMID:
16841631
12.

Psychopharmacologic treatment of pathologic aggression.

Fava M.

Psychiatr Clin North Am. 1997 Jun;20(2):427-51. Review.

PMID:
9196923
13.

Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.

Penzner JB, Dudas M, Saito E, Olshanskiy V, Parikh UH, Kapoor S, Chekuri R, Gadaleta D, Avedon J, Sheridan EM, Randell J, Malhotra AK, Kane JM, Correll CU.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):563-73. doi: 10.1089/cap.2009.0051.

14.

Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.

Ipser J, Stein DJ.

Psychopharmacology (Berl). 2007 Mar;191(1):127-40. Epub 2006 Sep 16. Review.

PMID:
16983542
15.

Conduct disorder in referred children and adolescents: clinical and therapeutic issues.

Masi G, Milone A, Manfredi A, Pari C, Paziente A, Millepiedi S.

Compr Psychiatry. 2008 Mar-Apr;49(2):146-53. doi: 10.1016/j.comppsych.2007.08.009. Epub 2007 Oct 24.

PMID:
18243886
16.

Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Wu EQ, Hodgkins P, Ben-Hamadi R, Setyawan J, Xie J, Sikirica V, Du EX, Yan SY, Erder MH.

CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000. Review.

PMID:
22712698
17.
18.

A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.

Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A.

J Am Acad Child Adolesc Psychiatry. 2004 Apr;43(4):420-9.

PMID:
15187802
19.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
20.

Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.

Gorman DA, Gardner DM, Murphy AL, Feldman M, Bélanger SA, Steele MM, Boylan K, Cochrane-Brink K, Goldade R, Soper PR, Ustina J, Pringsheim T.

Can J Psychiatry. 2015 Feb;60(2):62-76.

Items per page

Supplemental Content

Write to the Help Desk